Search hospitals > California > San Diego

Sharp Memorial Hospital

Claim this profile
San Diego, California 92123
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
144 reported clinical trials
6 medical researchers
Photo of Sharp Memorial Hospital in San DiegoPhoto of Sharp Memorial Hospital in San DiegoPhoto of Sharp Memorial Hospital in San Diego

Summary

Sharp Memorial Hospital is a medical facility located in San Diego, California. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lung Cancer, Heart Failure and other specialties. Sharp Memorial Hospital is involved with conducting 144 clinical trials across 290 conditions. There are 6 research doctors associated with this hospital, such as Charles H. Redfern, Raghava Gollapudi, Kai Zu, MD, and Robert M. Barone.

Area of expertise

1Breast Cancer
Global Leader
Sharp Memorial Hospital has run 27 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV
2Cancer
Global Leader
Sharp Memorial Hospital has run 17 trials for Cancer. Some of their research focus areas include:
Stage IV
HER2
Stage III

Top PIs

Clinical Trials running at Sharp Memorial Hospital

Cancer
Breast Cancer
Solid Tumors
Ovarian Cancer
Skin Cancer
Melanoma
Breast cancer
Endometrial Cancer
Parotid Gland Cancer
Lung Cancer
Image of trial facility.

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Image of trial facility.

MDNA11 + Pembrolizumab

for Cancer

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.
Recruiting1 award Phase 1 & 2
Image of trial facility.

Targeted Therapy

for Brain Cancer

This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Sharp Memorial Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security